Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Markus Haeberlein is active.

Publication


Featured researches published by Markus Haeberlein.


Advanced Drug Delivery Reviews | 2002

Computational approaches to the prediction of the blood-brain distribution

Ulf Norinder; Markus Haeberlein

This review attempts to summarise present knowledge related to the theoretical modelling of drug transport across the blood-brain barrier. Several computational protocols are described ranging from quantum mechanics-based approaches through molecular mechanics-related techniques to simple and fast procedures based on only the 2-D graph of the investigated structures. Amazingly, few descriptors have been shown to influence the derived relationships in a significant manner and a cornerstone in most of the described models are terms describing hydrogen bonding. A very quick quantitative assessment of the brain partitioning of a compound has also been devised using the following two rules: If N+O (the number of nitrogen and oxygen atoms) in a molecule is less than or equal to five, it has a high chance of entering the brain. The second rule predicts that if log P-(N+O) is positive then log BB is positive.


Archive | 2002

Therapeutic quinolone compounds with 5-ht-antagonistic properties

Marc Chapdelaine; Timothy Wayne Davenport; Markus Haeberlein; Carey Horchler; Edward Pierson; Daniel Sohn; John Mccauley


Archive | 2002

Therapeutic isoquinoline compounds

Christof AstraZeneca Wilmington Angst; Markus Haeberlein; Daniel AstraZeneca Wilmington Hill; Robert AstraZeneca Wilmington Jacobs; Gary Moore; Edward Pierson; Ashokkumar Bhikkappa Shenvi


Archive | 2002

Therapeutic chroman compounds

Marc AstraZeneca Wilmington Chapdelaine; Timothy AstraZeneca Wilmington Davenport; Markus Haeberlein; Carey AstraZeneca Wilmington Horchler; John AstraZeneca Wilmington Mccauley; Edward Pierson; Daniel Sohn


Archive | 2002

Therapeutic chromone compounds

Marc Chapdelaine; Timothy Davenport; Markus Haeberlein; Carey Horchler; John Mccauley; Edward Pierson; Daniel Sohn


Archive | 2004

Calculated Molecular Properties and Multivariate Statistical Analysis in Absorption Prediction

Ulf Norinder; Markus Haeberlein


Archive | 2005

Quinoline compounds with 5-HT-antagonistic properties for therapy

Marc Chapdelaine; Timothy Davenport; Markus Haeberlein; Carey Horchler; John Mccauley; Edward Pierson; Daniel Sohn


Archive | 2009

Therapeutic benzopyranone compounds used as intermediates.

Jerome Chapdelaine Marc; Timothy Davenport; Markus Haeberlein; Carey Horchler; John Mccauley; Edward Pierson


Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability, Volume 40, Second Edition | 2008

Computational Absorption Prediction

Christel A. S. Bergström; Markus Haeberlein; Ulf Norinder


Archive | 2007

Therapeutic Heterocyclic Compounds 507

Edward Pierson; Daniel Sohn; Markus Haeberlein; Timothy Wayne Davenport; Marc Chapdelaine; Carey Horchler; John Mccauley

Collaboration


Dive into the Markus Haeberlein's collaboration.

Researchain Logo
Decentralizing Knowledge